Company overview
AnteoTech develops niche diagnostic products and solutions for healthcare, agriculture, and veterinary sciences using patented metal-ion-based technology. They offer ready-to-use kits with AnteoBind™ for surface activation and bioconjugation on microspheres, nanospheres, and planar surfaces. Their R&D is ISO 9001 compliant, supporting in-vitro diagnostics and advanced material solutions.
AnteoTech is listed in the NovaPharmaNews Supplier Hub as a Diagnostics & Testing partner serving United States & Americas. Core focus areas include anteotech, anteobind, bioconjugation, life sciences supplier, diagnostic kits, iso 9001.
Industry categories: Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://anteotech.com
- Categories
- Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- anteotech, anteobind, bioconjugation, life sciences supplier, diagnostic kits, iso 9001
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What life sciences products does AnteoTech offer?
- AnteoTech provides ready-to-use kits incorporating AnteoBind™ to activate surfaces for bioconjugation, compatible with microspheres, nanospheres, and planar surfaces for diagnostic applications.
- What are AnteoTech's regulatory compliances?
- Their R&D systems and processes are compliant with ISO 9001 industry standards.
- Where is AnteoTech located and what are their capabilities?
- Headquartered in Brisbane, Australia (Eight Mile Plains, Queensland), with patented technology for life sciences diagnostics and global development focus.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
